3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Radiotherapy
7
Biopsy
6
Magnetic Resonance Spectroscopy
5
Cisplatin
5
Blood Specimen Collection
5
Standard of Care
4
Radiotherapy, Intensity-Modulated
4
Fluorodeoxyglucose F18
4
pembrolizumab
3
Ultrasonography
3
Sentinel Lymph Node Biopsy
3
Radiosurgery
3
Practice Guidelines as Topic
3
Magnetic Resonance Imaging
3
Immunohistochemistry
3
Chemoradiotherapy
3
Cetuximab
3
Radiotherapy, Conformal
2
Positron-Emission Tomography
2
Positron Emission Tomography Computed Tomography
2
Nivolumab
2
Nicotine Replacement Therapy
2
Methods
2
Educational Status
2
Dexamethasone
2
Acupuncture Therapy
2
temoporfin
1
sargramostim
1
pimonidazole
1
iso-sulfan blue
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Squamous Cell Carcinoma of Head and Neck
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled